mRNA Vaccine May Help Prevent Recurrence and Spread
Share on PinterestA personalized mRNA melanoma vaccine developed by Moderna and Merck shows promise in reducing recurrence and spread. Iparraguirre Recio · Moment/Getty A late-stage trial found that a personalized mRNA therapy for melanoma outperformed Keytruda alone on two important measures of treatment success. The experimental treatment is tailored to the unique mutations in each […]
